Results 71 to 80 of about 180,953 (150)

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Journal of Hematology & Oncology, 2019
Background Low-dose post-transplant cyclophosphamide (PTCy) in conjunction with anti-thymocyte globulin (ATG) appears as a potentially effective graft-versus-host disease (GVHD) prevention strategy in haploidentical hematopoietic cell transplant (haplo ...
Yu Wang, De-Pei Wu, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Wen-Jing Yu, Yang Xu, Fen Huang, Xiao-Jun Huang   +9 more
doaj   +1 more source

Arctigenin Attenuates Ischemia/Reperfusion Induced Ventricular Arrhythmias by Decreasing Oxidative Stress in Rats

Cellular Physiology and Biochemistry, 2018
Background/Aims: Arctigenin (ATG) has been shown to possess anti-inflammatory, immunemodulatory, anti-viral, anti-microbial, anti-carcinogenic, vasodilatory and anti-platelet aggregation properties.
Jing Yang, Hong-shan Yin, Ya-jing Cao, Zhi-an Jiang, Yong-jun Li, Mu-chun Song, Yong-fei Wang, Zhi-hua Wang, Rong Yang, Yun-fa Jiang, Jin-peng Sun, Bo-yi Liu, Chuan Wang   +12 more
doaj   +1 more source

Identification of Amino Acid Residues in Angiotensin II Type 1 Receptor Sensing Mechanical Stretch and Function in Cardiomyocyte Hypertrophy

Cellular Physiology and Biochemistry, 2015
Background/Aims: Angiotensin II (AngII) type 1 receptor (AT1R) could be activated by mechanical stress without the involvement of AngII during the development of cardiac hypertrophy. We aimed to identify sensing sites of AT1R for activation by mechanical
Guoliang Jiang, Hui Gong, Yuhong Niu, Chunjie Yang, Shijun Wang, Zhidan Chen, Yong Ye, Ning Zhou, Guoping Zhang, Junbo Ge, Yunzeng Zou   +10 more
doaj   +1 more source

Prophylaktische zytolytische Behandlung nach Herztransplantation: ATG versus OKT3. [Preventive cytolytic treatment following heart transplantation: ATG versus OKT3]

, 1991
The postoperative prophylactic cytolytic therapy with rabbit-ATG and OKT3 after heart transplantation are compared. The first 20 recipients were treated with ATG (5 days), the next 20 with OKT3 (14 days).
Schonbeck, M., Laske, A., Carrel, T., von Segesser, L. K., Gallino, A., Turina, M., Bauer, E., Leonardi, L.   +7 more
core   +1 more source

Effect of plasmapheresis on ATG (Thymoglobulin) clearance prior to adoptive T cell transfer

, 2019
The effect of anti-thymocyte globulin (ATG) on the outcome of hematopoietic stem cell transplantation (SCT) is dependent on formulation, dose and exposure. However, ATG levels are not routinely measured and therapeutic levels are not well defined.
Cameron I. Curley, Geoffrey R. Hill, Midori Nakagaki, Siok-Keen Tey, Curley, Cameron I., Kari Mudie, Ping Zhang, Nakagaki, Midori, Mudie, Kari, Jason A. Roberts, Tey, Siok-Keen, Zhang, Ping, Hill, Geoffrey R., Roberts, Jason A.   +13 more
core   +1 more source

Re-exploration of all ATG genes

Most autophagy-related (ATG) genes have been identified and characterized through studies using the budding yeast Saccharomyces cerevisiae. However, there are no studies that comprehensively compare the contribution of each ATG gene to non-selective bulk
Kentaro Furukawa, Tamara Ginevskaia, Tomotake Kanki   +2 more
core   +1 more source

Representative images showing immunohistochemical staining for ATG-5 in non-tumorous and GC tumor tissues.

, 2014
(A) ATG-5 staining in non-cancerous gastric tissues scored 285(×200); (B) ATG-5 staining in GC tumor tissues scored 50(×400); (C) ATG-5 staining in GC tumor tissues scored 270(×400); (D) ATG-5 staining in GC tumor tissues scored 400(×200).
Jinxiang Chen (646451), Jin Huang (146235), Zhikang Chen (646453), Weijie Yuan (490086), Zhenghao Deng (646452), Jie Ge (425582), Zihua Chen (646450)   +6 more
core   +1 more source

Enhanced neoangiogenesis by ATG after AMI.

, 2012
ATG treated animals showed a higher vessel density in the border zone between scar tissue and viable myocardium compared to untreated controls as shown in anti-vWF stained specimens (a,b,c).
Michael Lichtenauer (110112), Andreas Mitterbauer (110128), Matthias Zimmermann (110132), Stefanie Nickl (110125), Matthias Hasun (110122), Gregor Werba (110114), Mariann Gyöngyösi (110138), Lucian Beer (110115), Walter Klepetko (110147), Bruno Karl Podesser (110143), Michael Mildner (110113), Andrea Baumgartner (110119), Konrad Hoetzenecker (110117), Hendrik Jan Ankersmit (110152)   +13 more
core   +1 more source

Chronic graft-versus-host disease : long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius

, 2011
Previous randomized graft-versus-host disease (GVHD)-prophylaxis trials have failed to demonstrate reduced incidence and severity of chronic GVHD (cGVHD).
Bertz, Hartmut, Matthias Stelljes, Tapani Ruutu, ATG-Fresenius Trial Group,, Axel R. Zander, Maertens, Johan, Schwerdtfeger, Rainer, Werner Linkesch, Volin, Liisa, Stelljes, Matthias, Olga Grishina, Matthias Egger, Gérard Socié, Karin Kolbe, Dominik A. Heim, Mayer, Jiri, Hartmut Bertz, null null, Liisa Volin, Bethge, Wolfgang A., Egger, Matthias, Hellmut D. Ottinger, Martin Bornhäuser, Heim, D. A., Zander, Axel R., Wolfgang A. Bethge, Ernst Holler, Hans-Jochem Kolb, Jürgen Finke, Bethge, Wolfgang, Holler, Ernst, Kolbe, Karin, Rainer Schwerdtfeger, Socié, Gérard, Vladimir Koza, Johan A. Maertens, Linkesch, Werner, Kolb, Hans-Jochem, Claudia Schmoor, Koza, Vladimir, Grishina, Olga, ATG-Fresenius Trial Group, [Study group], Bornhäuser, Martin, Ottinger, Hellmut D., Hermann Einsele, Linkesch, W., Jiri Mayer, Maertens, Johan A., Finke, Jürgen, Ruutu, Tapani, Heim, Dominik A., Schmoor, Claudia, Einsele, Hermann   +52 more
core   +1 more source

Comparing two different doses of anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation for transfusion-dependent thalassemia: an open-label, randomized clinical trial

Therapeutic Advances in Hematology
Background: Anti-thymocyte globulin (ATG) is used as prophylaxis for graft-versus-host disease (GvHD) and graft failure (GF) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with transfusion-dependent thalassemia (TDT ...
Qiulin Huang, Rongrong Liu, Baoshi Zheng, Lianjin Liu, Hongwen Xiao, Meiqing Wu, Lingling Shi, Gaohui Yang, Zhenbin Wei, Qi Zhou, Yinghua Chen, Yanye Liu, Jing Fan, Xuemei Zhou, Ruolin Li, Zhiyu Zeng, Zhongming Zhang, Yongrong Lai   +17 more
doaj   +1 more source